Preclinical data show potential effectiveness of CRISPR Therapeutics’ off-the-shelf CAR-T cells; shares up 2% after … – Seeking Alpha
|
Preclinical data show potential effectiveness of CRISPR Therapeutics' off-the-shelf CAR–T cells; shares up 2% after …
Seeking Alpha Gene editor CRISPR Therapeutics (NASDAQ:CRSP) is up 2% after hours on modest volume on the heels of its announcement of encouraging preclinical data supporting the potential efficacy of its off-the-shelf CAR-T candidates. The results were presented at … |
